Faical Miyara
CIK: 0002142869
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AAPG
ASCENTAGE PHARMA GROUP INTERNATIONAL
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Miyara Faical
Miyara Faical (SEC CIK 0002142869) files insider reports with the SEC as Chief Business Officer of ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG).
Signal8 holds 1 ownership filing by Miyara Faical, a Form 3, filed on Jun 29, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Miyara Faical's filings is in ROCKVILLE, MD.
Other insiders filing for ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
- Zhai Yifan, Chief Medical Officer
- Yang Dajun, Chairman and CEO
- Misra Veet, Chief Financial Officer
- Cao Jin, Chief Accounting Officer
- Wei Ren, Director
- Ye Changqing, Director